Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 04, 2026, 11:11 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011864 <b>Size:</b> 633 KB

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 04, 2026, 11:10 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011863 <b>Size:</b> 639 KB

Comment Full text

TORONTO DOMINION BANK (TD)

  • SEC News
  • May 04, 2026, 11:10 UTC
  • 0
  • 0 comments

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001140361-26-018741 <b>Size:</b> 1 MB

Comment Full text

SUPERIOR GROUP OF COMPANIES, INC. (SGC)

  • SEC News
  • May 04, 2026, 11:09 UTC
  • 0
  • 1 comments

(30% Negative) SUPERIOR GROUP OF COMPANIES, INC. (SGC) Reports Q2 2026 Financial Results

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 04, 2026, 11:08 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011862 <b>Size:</b> 989 KB

Comment Full text

AXSOME THERAPEUTICS, INC. (AXSM)

  • SEC News
  • May 04, 2026, 11:07 UTC
  • 0
  • 1 comments

(30% Negative) AXSOME THERAPEUTICS, INC. (AXSM) Reports Q2 2026 Financial Results

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 04, 2026, 11:07 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011861 <b>Size:</b> 928 KB

Comment Full text

IFAST CORPORATION LTD. (AIY)

  • SEC News
  • May 04, 2026, 11:07 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Tammie Tham

Comment Full text

IFAST CORPORATION LTD. (AIY)

  • SEC News
  • May 04, 2026, 11:07 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Mark Duncan

Comment Full text

IFAST CORPORATION LTD. (AIY)

  • SEC News
  • May 04, 2026, 11:07 UTC
  • 0
  • 0 comments

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Lim Wee Kian

Comment Full text
  • Previous
  • 1121
  • 1122
  • 1123
  • 1124
  • 1125
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158460)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin